1 H spectrum (600 MHz) of 4′-((3,4,5-tribromo-1H-pyrrol-2-yl)methyl)phenol
(1) in DMSO-d 6 . Figure S2 . COSY spectrum (600 MHz) of (1) in DMSO-d 6 . Figure S3 . HSQC spectrum (600 MHz) of (1) in DMSO-d 6 . Figure S4 . HMBC spectrum (600 MHz) of (1) in DMSO-d 6 . Figure S5 .
(1) in CDCl3. Figure S6 . 13 C NMR spectrum (125 MHz) of (1) in CDCl 3 . Figure S7 . COSY spectrum (600 MHz) of (1) in CDCl 3 . Figure S8 . HSQC spectrum (600 MHz) of (1) in CDCl 3 . Figure S9 . HMBC spectrum (600 MHz) of (1) in CDCl 3 J CH = 7.5 Hz. Figure S10 . HMBC spectrum (600 MHz) of (1) in CDCl 3 J CH = 12 Hz. Figure S11 . 1 H spectrum (600 MHz) of (1) in CD 3 OD.
Figure S12.
13 C NMR spectrum (125 MHz) of (1) in CD 3 OD.
Figure S13. HSQC spectrum (600 MHz) of (1) in CD 3 OD. Figure S14 . HMBC spectrum (600 MHz) of (1) in CD 3 OD. Table S1 . NMR data (600 MHz and 125 MHz, Figures S1-S14) for 4′-((3,4,5-tribromo-1H-pyrrol-2-yl)methyl)phenol (1). Figure S15 . 1 H spectrum (600 MHz) of Korormicin G (2) in CDCl 3 . Figure S16 . COSY spectrum (600 MHz) of (2) in CDCl 3 . Figure S17 . HSQC spectrum (600 MHz) of (2) in CDCl 3 . Figure S18 . HMBC spectrum (600 MHz) of (2) in CDCl 3 . Figure S19 . 1 H spectrum (600 MHz) of Korormicin H (3) in DMSO-d 6 .
Figure S20.
13 C NMR spectrum (125 MHz) of (2) in DMSO-d 6 . Figure S21 . COSY spectrum (600 MHz) of (3) in DMSO-d 6 . Figure S22 . HSQC spectrum (600 MHz) of (3) in DMSO-d 6 . Figure S23 . HMBC spectrum (600 MHz) of (3) in DMSO-d 6 . Figure S24 . 1 H spectrum (600 MHz) of Korormicin I (4) in CDCl 3 . Figure S25 . COSY spectrum (600 MHz) of (4) in CDCl 3 . Figure S26 . HSQC spectrum (600 MHz) of (4) in CDCl 3 . Figure S27 . 1 H spectrum (600 MHz) of Korormicin I (4) in DMSO-d 6 .
Figure S28.
13 C NMR spectrum (125 MHz) of (4) in DMSO-d 6 . Figure S29 . COSY spectrum (600 MHz) of (4) in DMSO-d 6 . Figure S30 . HSQC spectrum (600 MHz) of (4) in DMSO-d 6 . Figure S31 . HMBC spectrum (600 MHz; cnst13=12) of (4) in DMSO-d 6 . Figure S32 . HMBC spectrum (600 MHz; cnst13=7.5) of (4) in DMSO-d 6 . Figure S33 . 1 H spectrum (600 MHz) of Korormicin J (5) in CDCl 3 . Figure S34 . COSY spectrum (600 MHz) of (5) in CDCl 3 . Figure S35 . HSQC spectrum (600 MHz) of (5) in CDCl 3 . Figure S36 . 1 H spectrum (600 MHz) of Korormicin K (6) in CDCl 3 . Figure S37 . COSY spectrum (600 MHz) of (6) in CDCl 3 . Figure S38 . HSQC spectrum (600 MHz) of (6) in CDCl 3 . Figure S39 . HMBC spectrum (600 MHz) of (6) in CDCl 3 . Figure S40 . Selective nOe spectrum (600 MHz) of (6); H-3 in CDCl3. 
Figure S6.
13 C NMR spectrum (125 MHz) of (1) in CDCl 3 .
S5
Figure S7. COSY spectrum (600 MHz) of (1) in CDCl 3 . Figure S8 . HSQC spectrum (600 MHz) of (1) in CDCl 3 .
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Figure S9. HMBC spectrum (600 MHz) of (1) in CDCl 3 J CH = 7.5 Hz. Figure S10 . HMBC spectrum (600 MHz) of (1) in CDCl 3 J CH = 12 Hz.
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Figure S11. 1 H spectrum (600 MHz) of (1) in CD 3 OD.
Figure S12.
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Figure S13. HSQC spectrum (600 MHz) of (1) in CD 3 OD. Figure S14 . HMBC spectrum (600 MHz) of (1) in CD 3 OD. Table S1 . NMR data (600 MHz and 125 MHz, Figures S1-S14) for 4′-((3,4,5-tribromo-1H-pyrrol-2-yl)methyl)phenol (1). 
